EVENTS_ See all
Access to Treatment (ATT)

Access to HIV treatment in Central and South East Europe (ATT) is an ongoing program of NeLP seaking to identify and address obstacles to access to modern treatments, access to generic medications, regular access to drugs, access for everyone who needs treatment, access to PEP and early detection of HIV.

Initiating this program ment to contribute towards changing the perception of HIV in Central and South East Europe, as well as towards an increased public attention to HIV in these low prevalence settings.

Within the first stage of the project in 2014 NeLP identified major obstacles for quality treatment and tried to find the best strategies for national and regional ac-tions. One of the results of these efforts was the Call for Action, which challenges governments, pharmaceutical companies, and the affected communities to increase their efforts towards securing sustainable and quality treatment.

 

Identified Challenges

The challenges we face include:

  • limited and outdated treatment options,
  • including limited pediatric treatments;
  • dangerous and unacceptable treatment interruptions that can lead to resistant forms
  • of HIV;
  • inadequate planning of budget for treatment and inefficient funding mechanisms;
  • lack of registered medicines and delayed decisions for reimbursement;
  • systemic obstacles to timely start of antiretroviral therapy, such as lack of health insurance for
  • certain affected individuals or groups.

These are due to the lack of attention and commitment, strategic planning and sufficient funds to ensure a sustainable supply of quality medicines and diagnostic tools, as well as comprehensive care.

Therefore, we call on governments, the pharmaceutical companies, and the affected community to increase their efforts in securing sustainable and quality treatment.

 

Strategies for Solutions

The strategies developed within ATT are focusing on:

  • Increasing awareness of weaknesses in the health system in order to make it more functional
  • Ensuring long-term solutions
  • Using regional experiences in particular countries to address similar problems in others where
  • possible (NOTE: there is a unique situation in our region where some countries have national health
  • insurance systems and some do not)
  • Building international support
  • Forming partnerships and increasing the level of dialogue with different stakeholders
  • Working with media
  • Educating and empowering patients and healthcare workers
  • Collecting robust data on access issues and ensuring a correlation between demand and supply
  • Increasing competition and breaking monopoly in the market by inviting different pharma companies to offer their drugs and including private pharmacies in the distribution of medicines
  • Ensuring the quality of treatment
  • Including the community in the decision-making process

 

Call for Action

We know that the number of HIV infections is growing steadily in Central and South East Europe. While HIV prevalence is still relatively low, we still encounter problems in access to HIV treatment.

These are due to the lack of attention and commitment, strategic planning and sufficient funds to ensure a sustainable supply of quality medicines and diagnostic tools, as well as comprehensive care.

Therefore, we call on governments, the pharmaceutical companies, and the affected community to increase their efforts in securing sustainable and quality treatment.

As a community we pledge our cooperation to fulfil these important duties. We call on our members to contribute to improved access to treatment through continuous monitoring and providing evidence-based recommendations.

The Call for action is available here.